An asymmetric tetrabody is a potent and efficacious agonist of the erythropoietin receptor in vitro and in vivo is a research paper published in Protein Science (2025). On theSindex it has a DataRank of 0. It has been cited 2 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Canada Foundation for Innovation
Grant: IOF‐33363
National Institutes of Health
Grant: R01 DK081423
National Institutes of Health
Grant: R01 DK115703
National Institutes of Health
Grant: R01 DK128208
National Institutes of Health
Grant: R01 HL089966
National Institutes of Health
Grant: R01 HL159994
Canadian Institutes of Health Research
Grant: PJT‐159640
Canadian Cancer Society Research Institute
Grant: 704757
CIHR
Grant: PJT-159640
Canada Foundation for Innovation
Grant: IOF-33363
Canadian Institutes of Health Research
Grant: unidentified
unidentified
National Institutes of Health
Grant: 1R01DK128208-01
The Relation of Soluble Klotho with Cardiovascular Disease, Chronic Kidney Disease Progression, and Blood Pressure in the Systolic Blood Pressure Intervention Trial
National Institutes of Health
Grant: 5R01HL089966-05
Erythropoietin receptor signaling in erythropoiesis
National Institutes of Health
Grant: 1R01HL159994-01A1
Impact of Dietary Phosphate Excess on Exercise Capacity and Visceral Adiposity
National Institutes of Health
Grant: 5R01DK081423-12
Pathogenesis of Uric Acid Nephrolithiasis
National Institutes of Health
Grant: 5R01DK115703-05
Origin of Excess Acid in Uric Acid Urolithiasis
National Institutes of Health
Grant: 3R01DK119497-03S1
Lymphatics and lymphangiogenesis in kidney function and inflammation
FWCI
2.12
Citation Percentile
0.9%
Citation Trend
Fields of Study
MeSH Terms
Keywords